Clinical Supply Leader expands its Editorial Advisory Board expertise with the addition of Éamonn McArdle (Allergy Therapeutics) and Juan Hernandez (Bensen Solutions).
- The Silent Threat To Clinical Trials: Why Shelf-Life Management Can Determine Study Success
- CDMO Quality Oversight: How FDA And Pharma Leaders Are Rethinking Data, AI, And Culture
- AI Is Only As Good As The Data Behind Your Clinical Trial Supply Chain
- Five Places Where AI Stalls In Clinical Supply
- ADC CDMO Selection For Small Biotech
- More Than Half The Drug We Make Never Reaches A Patient
- Lessons In Forecasting Discipline From A $40B Supply Chain
- Clinical Supply When There's No Drug To Ship
ON-DEMAND WEBINARS
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.
Consider these strategies when anticipating and mitigating disruptions, and how future innovations and trends will continue to shape the logistics industry.
Join IRT industry veteran and drug supply expert Stefan Dürr for a discussion about how to reduce the impact of both traditional and emerging macroeconomic pressures on clinical trial supply.
Explore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Sales Advice Data Analytics]( "Complex Randomization Delivered Successfully")
Complex Randomization Delivered SuccessfullyLearn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
-
![GettyImages-2036497889-lab-computer-research]( "RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It Matters")
RTSM Reusability: What It Is, Why Most Systems Lack It, And Why It MattersExplore why RTSM should be viewed as a system for managing change. Learn how platform-based reusability reduces UAT churn, preserves institutional memory, and stabilizes mid-study amendments.
-
![GettyImages-1189150676-Medicinal_Marijuana_Cannabis_ControlledSubstance]( "Controlled Substances In Clinical Trials")
Controlled Substances In Clinical TrialsHandling controlled substances presents layers of complexity. Partnering with an experienced CDMO is essential for managing scheduled materials during clinical studies.
-
![GettyImages-2189597043-production-facility-laptop-software]( "How A Rare Disease Biotech Replaced Manual Processes With RTSM Software")
How A Rare Disease Biotech Replaced Manual Processes With RTSM SoftwareDiscover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
![03 West]( "Sample Sizes For Performance Testing Of Combination Products, Packaging")
Sample Sizes For Performance Testing Of Combination Products, PackagingWhen developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.
-
![GettyImages-1404326328 computer, research]( "From Frustration To Organization: An SSO Platform For Trial Sites")
From Frustration To Organization: An SSO Platform For Trial SitesTo reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.
-
![Internet-Medical-Things-iStock-914789708]( "How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers")
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment NumbersExplore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
![GettyImages-970394878-genetic-engineering-gene-editing-dna]( "Inside A Gene Therapy Facility, Commercialization & Industrialization Project")
Inside A Gene Therapy Facility, Commercialization & Industrialization ProjectAn inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.
-
![GettyImages-1751848523-meeting-evaluation-charts-table]( "Writing Effective Clinical Regulatory Documents For Therapy Trials")
Writing Effective Clinical Regulatory Documents For Therapy TrialsClinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
![deadlines time management-GettyImages-1350531674]( "How Modern RTSM Platforms Are Eliminating Delays")
How Modern RTSM Platforms Are Eliminating DelaysStop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
- Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors
- Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments?
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
